DJO enters $1.6bn merger agreement with ReAble
This article was originally published in Clinica
Executive Summary
Musculoskeletal and vascular health specialist DJO is set to enter the folds of private equity, after agreeing to be acquired by the Blackstone Group's ReAble Therapeutics in a transaction worth approximately $1.6bn.